Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of GLB-001 in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review
- Status
- WITHDRAWN
- Phase
- N/A
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
- Status
- RECRUITING
- Phase
- PHASE2
DEC-C and Thioguanine for R/R AML
- Status
- WITHDRAWN
- Phase
- PHASE2
Oral Azacitidine Maintenance Post-CPX 351
- Status
- RECRUITING
- Phase
- N/A
BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
- Status
- RECRUITING
- Phase
- NA
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Revumenib in Combination With 7+3 + Midostaurin in AML
- Status
- RECRUITING
- Phase
- PHASE1
MRD Response-adapted Allo-HSCT for Adverse-risk AML
- Status
- RECRUITING
- Phase
- NA
PTCy and ATG for MSD and MUD Transplants
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of REM-422 in Patients With AML or Higher Risk MDS
- Status
- RECRUITING
- Phase
- PHASE1
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
- Status
- RECRUITING
- Phase
- N/A
Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
- Status
- NOT_YET_RECRUITING
- Phase
- N/A